Skip to main content
    P

    Precision BioSciences Inc (DTIL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.05
    -0.23 (-3.16%)

    Market Cap: $277.88M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Precision BioSciences Inc (DTIL) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Precision BioSciences (DTIL) has a market cap of $277.88M and an enterprise value of $218.61M. Revenue grew 6353.01% over the last 12 months from the 12 months before. Its share count is up 132.13% from a year earlier.

    Total Valuation

    Enterprise value is 21.33% below the market cap, as cash exceeds debt.

    Market Cap$277.88M
    Enterprise Value$218.61M
    Latest price (Nov 17, 2026)$7.05

    Key Dates

    The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 10, 2027 (expected)
    Last Earnings DateNov 3, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 6.10% in the quarter ended Sep 30, 2026 and grew 94.03% a year over 2 years.

    Shares Outstanding27.43M
    Shares Change (YoY)+132.13%
    Shares Change (QoQ)+6.10%
    Share Count Growth (2Y CAGR)+94.03%

    Valuation Ratios

    Sales and book value multiples are 4.3x and 3.7x. Its year-end P/S ranged from 0.4x to 31.5x from 2019 to 2025.

    P/S Ratio4.3x
    Forward P/S24.5x
    P/B Ratio3.7x
    P/TBV Ratio3.8x

    Valuation history and multiples

    Price Statistics

    The stock is up 19.90% over 52 weeks and trades 0.57% above its 50-day average.

    Beta (1Y)0.43
    52-Week Change+19.90%
    1-Month Change+13.89%
    3-Month Change-17.06%
    6-Month Change+2.17%
    5-Year Change-97.52%
    Total Return (1Y)+19.90%
    Total Return (3Y CAGR)-18.65%
    Total Return (5Y CAGR)-51.93%
    Return vs SPY (1Y)+23.50%
    Max Drawdown (1Y)-37.82%
    Max Drawdown (3Y)-80.77%
    Sharpe Ratio (1Y)0.41
    Correlation with SPY (1Y)0.08
    50-Day Average$7.01
    200-Day Average$6.80
    52-Week Range$3.53 to $11.29
    RSI (14 Days)44.7
    Average Volume (20 Days)447.59K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 10.47x current liabilities, and total debt is 0.43x shareholder equity.

    Current Ratio10.47x
    Quick Ratio10.47x
    Debt / Equity0.43x
    Interest Coverage1.84x

    Returns and Efficiency

    Return on invested capital is -38.29% over the last 12 months, against a 5-year average of -57.52%.

    Return on Equity (ROE)-74.45%
    Return on Assets (ROA)-32.02%
    Return on Invested Capital (ROIC)-38.29%
    Return on Capital Employed (ROCE)-32.08%
    ROA (5Y Average)-24.82%
    ROIC (5Y Average)-57.52%
    Asset Turnover0.42x

    Scores

    DTIL has an Altman Z-Score of -4.96, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-4.96
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $45.04M over the last 12 months.

    Revenue$45.04M
    Revenue Growth (YoY)+6353.01%
    Gross Profit$45.04M
    Operating Income-$36.16M
    Pretax Income-$39.00M
    Net Income-$38.55M
    EBITDA-$33.32M
    EBIT-$35.96M
    Reported EPS (TTM)-$1.10

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 43.01% of the $120.38M in total assets.

    Cash and Equivalents$81.70M
    Total Debt$22.42M
    Net Cash$59.27M
    Net Cash Per Share$2.16
    Working Capital$78.31M
    Shareholder Equity$51.77M
    Book Value Per Share$1.89
    Tangible Book Value$50.71M
    Tangible Book Per Share$1.85
    Total Assets$120.38M
    Total Liabilities$68.60M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$51.76M
    FCF Per Share-$1.88
    Depreciation and Amortization$2.64M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -80.27%.

    Gross Margin100.00%
    Operating Margin-80.27%
    Pretax Margin-86.59%
    Net Margin-85.58%
    EBITDA Margin-73.97%
    EBIT Margin-79.84%

    Growth

    Revenue grew 10.93% a year over 3 years.

    Revenue Growth (3Y CAGR)+10.93%
    Revenue Growth (5Y CAGR)+7.13%
    Book Value Per Share Growth (2Y CAGR)+6.58%
    Tangible Book Per Share Growth (2Y CAGR)+7.04%

    Revenue and profit by year

    Dividends and Yields

    DTIL does not pay a dividend.

    Buyback Yield-46.03%
    Shareholder Yield-46.03%

    Stock Splits

    The last split was a 1-for-30 reverse split on Feb 14, 2024.

    Last Split DateFeb 14, 2024
    Split TypeReverse split
    Split Ratio1:30

    Peer Position

    Against 9 similar companies, DTIL has the 8th highest P/S.

    P/S Ratio4.3x vs 8.1x median
    ROIC-38.29% vs -42.31% median
    Revenue Growth (Trailing 4 Quarters, YoY)+6353.01% vs +9.35% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -49.49% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-49.49%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About DTIL

    What is DTIL's market cap?

    Precision BioSciences has a market cap of $277.88M. Its enterprise value, which adds debt and subtracts cash, is $218.61M.

    How many shares of DTIL are outstanding?

    Precision BioSciences has 27.43M shares outstanding. The count is up 132.13% from a year earlier.

    Does DTIL pay a dividend?

    No. Precision BioSciences does not pay a dividend.

    How much debt does DTIL have?

    Precision BioSciences has $22.42M of total debt and $81.70M of cash and equivalents, a net cash position of $59.27M.